Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
about
Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling.Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.Methyl 4-[5-(4-fluoro-phen-yl)-4-(pyridin-4-yl)-1H-imidazol-2-ylsulfan-yl]butanoateEfficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats.
P2860
Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
@en
Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
@nl
type
label
Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
@en
Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
@nl
prefLabel
Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
@en
Imidazole inhibitors of cytokine release: probing substituents in the 2 position.
@nl
P356
P1476
Imidazole inhibitors of cytokine release: probing substituents in the 2 position
@en
P2093
Hans-Günther Striegel
P304
P356
10.1021/JM020873Z
P407
P577
2002-10-01T00:00:00Z